201 related articles for article (PubMed ID: 12851624)
1. A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study.
Kopecky SL; Aviles RJ; Bell MR; Lobl JK; Tipping D; Frommell G; Ramsey K; Holland AE; Midei M; Jain A; Kellett M; Gibbons RJ;
Am Heart J; 2003 Jul; 146(1):146-52. PubMed ID: 12851624
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).
Ross AM; Gibbons RJ; Stone GW; Kloner RA; Alexander RW;
J Am Coll Cardiol; 2005 Jun; 45(11):1775-80. PubMed ID: 15936605
[TBL] [Abstract][Full Text] [Related]
4. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial.
Zohlnhöfer D; Ott I; Mehilli J; Schömig K; Michalk F; Ibrahim T; Meisetschläger G; von Wedel J; Bollwein H; Seyfarth M; Dirschinger J; Schmitt C; Schwaiger M; Kastrati A; Schömig A;
JAMA; 2006 Mar; 295(9):1003-10. PubMed ID: 16507801
[TBL] [Abstract][Full Text] [Related]
5. The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size.
Kristo G; Yoshimura Y; Ferraris SP; Jahania SA; Mentzer RM; Lasley RD
J Am Coll Surg; 2004 Oct; 199(4):586-94. PubMed ID: 15454144
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the safety and efficacy of the novel tetrapeptide ITF-1697 on infarct size after primary PTCA in acute myocardial infarction: a randomised, placebo-controlled pilot trial.
Syeda B; Kiss K; Modarressy K; Schönau K; Schukro C; Derntl M; Laggner A; Sochor H; Glogar D
Drugs R D; 2004; 5(3):141-51. PubMed ID: 15139775
[TBL] [Abstract][Full Text] [Related]
7. Effects of glucose-insulin-potassium solution on myocardial salvage and left ventricular function after primary angioplasty.
Castro PF; Larrain G; Baeza R; Corbalán R; Nazzal C; Greig DP; Miranda FP; Pérez O; Acevedo M; Marchant E; Olea E; Gonzalez R
Crit Care Med; 2003 Aug; 31(8):2152-5. PubMed ID: 12973173
[TBL] [Abstract][Full Text] [Related]
8. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
; Bates E; Bode C; Costa M; Gibson CM; Granger C; Green C; Grimes K; Harrington R; Huber K; Kleiman N; Mochly-Rosen D; Roe M; Sadowski Z; Solomon S; Widimsky P
Circulation; 2008 Feb; 117(7):886-96. PubMed ID: 18250271
[TBL] [Abstract][Full Text] [Related]
9. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study.
Faxon DP; Gibbons RJ; Chronos NA; Gurbel PA; Sheehan F;
J Am Coll Cardiol; 2002 Oct; 40(7):1199-204. PubMed ID: 12383565
[TBL] [Abstract][Full Text] [Related]
10. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction.
Chareonthaitawee P; Christian TF; Hirose K; Gibbons RJ; Rumberger JA
J Am Coll Cardiol; 1995 Mar; 25(3):567-73. PubMed ID: 7860898
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
12. Mechanical reperfusion in patients with acute myocardial infarction presenting more than 12 hours from symptom onset: a randomized controlled trial.
Schömig A; Mehilli J; Antoniucci D; Ndrepepa G; Markwardt C; Di Pede F; Nekolla SG; Schlotterbeck K; Schühlen H; Pache J; Seyfarth M; Martinoff S; Benzer W; Schmitt C; Dirschinger J; Schwaiger M; Kastrati A;
JAMA; 2005 Jun; 293(23):2865-72. PubMed ID: 15956631
[TBL] [Abstract][Full Text] [Related]
13. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial.
Stone GW; Webb J; Cox DA; Brodie BR; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Dulas D; Rutherford BD; Antoniucci D; Krucoff MW; Gibbons RJ; Jones D; Lansky AJ; Mehran R;
JAMA; 2005 Mar; 293(9):1063-72. PubMed ID: 15741528
[TBL] [Abstract][Full Text] [Related]
14. Incidence and importance of thrombolysis in myocardial infarction grade 3 flow after primary percutaneous transluminal coronary angioplasty for acute myocardial infarction.
Laster SB; O'Keefe JH; Gibbons RJ
Am J Cardiol; 1996 Sep; 78(6):623-6. PubMed ID: 8831393
[TBL] [Abstract][Full Text] [Related]
15. Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.
Kastrati A; Mehilli J; Schlotterbeck K; Dotzer F; Dirschinger J; Schmitt C; Nekolla SG; Seyfarth M; Martinoff S; Markwardt C; Clermont G; Gerbig HW; Leiss J; Schwaiger M; Schömig A;
JAMA; 2004 Feb; 291(8):947-54. PubMed ID: 14982910
[TBL] [Abstract][Full Text] [Related]
16. Routine thrombectomy in percutaneous coronary intervention for acute ST-segment-elevation myocardial infarction: a randomized, controlled trial.
Kaltoft A; Bøttcher M; Nielsen SS; Hansen HH; Terkelsen C; Maeng M; Kristensen J; Thuesen L; Krusell LR; Kristensen SD; Andersen HR; Lassen JF; Rasmussen K; Rehling M; Nielsen TT; Bøtker HE
Circulation; 2006 Jul; 114(1):40-7. PubMed ID: 16801464
[TBL] [Abstract][Full Text] [Related]
17. Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials.
Stone GW; Dixon SR; Grines CL; Cox DA; Webb JG; Brodie BR; Griffin JJ; Martin JL; Fahy M; Mehran R; Miller TD; Gibbons RJ; O'Neill WW
Am J Cardiol; 2007 Nov; 100(9):1370-5. PubMed ID: 17950792
[TBL] [Abstract][Full Text] [Related]
18. Three hours continuous injection of adenosine improved left ventricular function and infarct size in patients with ST-segment elevation myocardial infarction.
Zhang H; Tian NL; Hu ZY; Wang F; Chen L; Zhang YJ; Chen SL
Chin Med J (Engl); 2012 May; 125(10):1713-9. PubMed ID: 22800889
[TBL] [Abstract][Full Text] [Related]
19. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
20. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction.
Stone GW; Martin JL; de Boer MJ; Margheri M; Bramucci E; Blankenship JC; Metzger DC; Gibbons RJ; Lindsay BS; Weiner BH; Lansky AJ; Krucoff MW; Fahy M; Boscardin WJ;
Circ Cardiovasc Interv; 2009 Oct; 2(5):366-75. PubMed ID: 20031745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
